Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination.
作者信息
Collier Ai-Ris Y, McMahan Katherine, Jacob-Dolan Catherine, Liu Jinyan, Borducchi Erica N, Moss Bernard, Barouch Dan H
机构信息
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
出版信息
JAMA. 2024 Nov 19;332(19):1669-1672. doi: 10.1001/jama.2024.20951.
Abstract
摘要
相似文献
1
Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination.安卡拉痘苗病毒-巴伐利亚北欧公司疫苗接种后猴痘抗体反应的下降
JAMA. 2024 Nov 19;332(19):1669-1672. doi: 10.1001/jama.2024.20951.
2
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.儿童单次接种改良安卡拉-巴伐利亚北欧天花疫苗后的安全性、反应原性和免疫应答的早期评估：国家疫情应对。
Lancet Infect Dis. 2023 Sep;23(9):1042-1050. doi: 10.1016/S1473-3099(23)00270-0. Epub 2023 Jun 16.
3
Rapid Decline of Mpox Antibody Responses Following MVA-BN Vaccination.MVA-BN疫苗接种后猴痘抗体反应迅速下降。
medRxiv. 2024 Sep 11:2024.09.10.24313399. doi: 10.1101/2024.09.10.24313399.
4
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.2022 年 6 月至 8 月，法国里昂一项针对改良安卡拉痘苗接种以预防猴痘（曾用名：猴痘）的暴露后疫苗接种效果的回顾性观察研究。
Euro Surveill. 2022 Dec;27(50). doi: 10.2807/1560-7917.ES.2022.27.50.2200882.
5
The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response.两剂次的MVA-BN猴痘疫苗诱导出一种非持久性且低亲和力的猴痘病毒特异性抗体反应。
J Virol. 2025 Mar 31:e0025325. doi: 10.1128/jvi.00253-25.
6
Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial.改良安卡拉痘苗-巴伐利亚北欧疫苗预防猴痘感染的效果：目标试验模拟。
BMJ. 2024 Sep 11;386:e078243. doi: 10.1136/bmj-2023-078243.
7
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.作为猴痘预防措施使用的MVA-BN疫苗的免疫原性：一项前瞻性、单中心队列研究及反应的转录组预测因子分析。
Lancet Microbe. 2025 Jun;6(6):101045. doi: 10.1016/j.lanmic.2024.101045. Epub 2025 Apr 23.
8
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.单次和双剂量接种改良安卡拉牛痘疫苗-巴伐利亚北欧株可诱导持久的 B 细胞记忆应答，与复制天花疫苗相当。
J Infect Dis. 2023 May 12;227(10):1203-1213. doi: 10.1093/infdis/jiac455.
9
Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox.接种安卡拉痘苗病毒-巴伐利亚北欧公司（MVA-BN）疫苗预防猴痘后的短期不良事件。
JAMA. 2023 Jun 20;329(23):2091-2094. doi: 10.1001/jama.2023.7683.
10
Vaccines against mpox: MVA-BN and LC16m8.针对猴痘的疫苗：MVA-BN 和 LC16m8。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):796-811. doi: 10.1080/14760584.2024.2397006. Epub 2024 Sep 1.
引用本文的文献
1
Immune Response to MVA-BN and Prior Smallpox Vaccination in People With HIV or at Risk for HIV Acquisition.HIV感染者或有感染HIV风险人群对MVA-BN及既往天花疫苗接种的免疫反应。
Open Forum Infect Dis. 2025 Aug 14;12(8):ofaf497. doi: 10.1093/ofid/ofaf497. eCollection 2025 Aug.
2
Serological differentiation between naturally acquired mpox and MVA-BN-vaccine induced antibody responses using ratios of MPXV and VACV antigen pairs in the MSD immunoassay.在MSD免疫测定中，使用MPXV和VACV抗原对的比例对自然获得的猴痘和MVA-BN疫苗诱导的抗体反应进行血清学区分。
Microbiol Spectr. 2025 Aug 8:e0018225. doi: 10.1128/spectrum.00182-25.
3
Efficacy of modified-vaccinia Ankara vaccine as pre- and post-exposure prophylaxis against monkeypox sexual transmission in non-human primate model.安卡拉痘苗病毒改良疫苗作为暴露前和暴露后预防非人灵长类动物模型中猴痘性传播的有效性。
Nat Commun. 2025 Aug 7;16(1):7306. doi: 10.1038/s41467-025-62681-2.
4
Molecular detection and isolation of clade Ib monkeypox virus, Canada, November 2024.2024年11月，加拿大，进化枝Ib型猴痘病毒的分子检测与分离
Euro Surveill. 2025 Jun;30(25). doi: 10.2807/1560-7917.ES.2025.30.25.2500402.
5
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines.基于非复制型和复制型痘苗病毒的疫苗所诱导的猴痘免疫和牛痘免疫差异。
Vaccines (Basel). 2025 May 14;13(5):520. doi: 10.3390/vaccines13050520.
6
Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates.猴痘多蛋白病毒样纳米颗粒疫苗在小鼠和非人灵长类动物中诱导产生中和抗体和保护性抗体。
Nat Commun. 2025 May 21;16(1):4726. doi: 10.1038/s41467-025-59826-8.
7
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.与MVA-BN疫苗接种相比，T细胞对猴痘病毒感染的记忆反应表现出更强的效应功能和迁移潜力。
Nat Commun. 2025 May 10;16(1):4362. doi: 10.1038/s41467-025-59370-5.
8
Humoral Immunity Against Orthopoxvirus in Vaccinated and Unvaccinated Individuals during 2022 Mpox Outbreak.2022年猴痘疫情期间接种疫苗和未接种疫苗个体针对正痘病毒的体液免疫
medRxiv. 2025 Mar 17:2025.03.16.25324075. doi: 10.1101/2025.03.16.25324075.
9
Viral introductions and return to baseline sexual behaviors maintain low-level mpox incidence in Los Angeles County, USA, 2023-2024.2023 - 2024年，病毒传入及性行为回归基线导致美国洛杉矶县猴痘发病率维持在低水平。
medRxiv. 2025 Mar 15:2025.03.14.25323999. doi: 10.1101/2025.03.14.25323999.
10
Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines.下一代山羊痘病毒和猴痘病毒疫苗的研发方法。
Viruses. 2025 Jan 27;17(2):186. doi: 10.3390/v17020186.
本文引用的文献
1
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates.mRNA 或改良安卡拉痘苗病毒疫苗对非人灵长类动物预防猴痘的效果比较。
Cell. 2024 Oct 3;187(20):5540-5553.e10. doi: 10.1016/j.cell.2024.08.043. Epub 2024 Sep 4.
2
WHO Director-General declares mpox outbreak a public health emergency of international concern.世界卫生组织总干事宣布猴痘疫情构成“国际关注的突发公共卫生事件”。
Saudi Med J. 2024 Aug;45(9):1002-1003.
3
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.恒河猴中 ACAM2000、MVA 和基于载体的亚单位疫苗对猴痘的免疫原性和保护效力比较。
Sci Transl Med. 2024 Mar 27;16(740):eadl4317. doi: 10.1126/scitranslmed.adl4317.
4
Notes from the Field: Emergence of an Mpox Cluster Primarily Affecting Persons Previously Vaccinated Against Mpox - Chicago, Illinois, March 18-June 12, 2023.实地记录：主要影响曾接种过猴痘疫苗人群的猴痘聚集性疫情——伊利诺伊州芝加哥，2023年3月18日至6月12日
MMWR Morb Mortal Wkly Rep. 2023 Jun 23;72(25):696-698. doi: 10.15585/mmwr.mm7225a6.
5
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.美国 JYNNEOS 疫苗对猴痘疾病的有效性。
N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18.
6
Update on the Monkeypox Outbreak.猴痘疫情最新情况
JAMA. 2022 Sep 13;328(10):921-922. doi: 10.1001/jama.2022.14857.
Zotero 插件